Topics on Clinical Genomics to be discussed will include:
- Clinical genomics is just one of many modalities that will influence decision making in the clinic but it is only one element within a broader armamentarium of new molecular tools when used in concert will elucidate a more meaningful taxonomy of disease
- At the provider level, how are AI systems being designed with the user in mind and how is the exponential pace of development becoming a critical issue for clinicians being informed about the real value to their practice.
- How do we bridge the knowledge between data science and medicine, what is the bare minimum of knowledge a physician needs to know in order to converse in a meaningful way with a data scientist
- How do we tackle issues around Data Structure/ Ownership and Privacy?
Amalio Telenti, Chief Data Scientist, Director of the Genomics institute at Scripps Translational institute
Shumei Kato, MD, Assistant Clinical Professor, Experimental Therapeutics, GI Medical Oncology & Rare Tumor Clinic Division of Hematology & Oncology and Center for Personalized Cancer Therapy, UC San Diego Moores Cancer Center
Kevin Puylaert, Vice President of SOPHiA GENETICS’ North America